"Benefits of Pharmacogenomics in Drug Development - Earlier Launch of Drugs ..."

Wataru Ohashi, Hiroshi Tanaka (2010)

> Home

Details and statistics

DOI: 10.1007/S10916-009-9284-7

access: closed

type: Journal Article

metadata version: 2020-06-08

- view
  - electronic edition via DOI
  - unpaywalled version
  authority control:
- export record
  dblp key:
  - journals/jms/OhashiT10
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/jms/OhashiT10
Wataru Ohashi, Hiroshi Tanaka:
Benefits of Pharmacogenomics in Drug Development - Earlier Launch of Drugs and Less Adverse Events. J. Medical Syst. 34(4): 701-707 (2010)

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.